Marek Kuźniewski

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Serum levels of unique miR-551-5p and endothelial-specific miR-126a-5p allow discrimination of patients in the early phase of acute pancreatitis

Beata Kuśnierz‐Cabala, Ewelina Nowak, Mateusz Sporek et al. · Pancreatology · 2015 · 51 citations · Full text

Medicine, Molecular Medicine, Pathology +13

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients

Anna Buda-Nowak, Jakub Kucharz, Paulina Dumnicka et al. · Medical Oncology · 2017 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Serum uromodulin concentrations correlate with glomerular filtration rate in patients with chronic kidney disease

Danuta Fedak, Marek Kuźniewski, A. Fugiel et al. · Polskie Archiwum Medycyny Wewnętrznej · 2016 · 39 citations · Full text

Medicine, Nephrology, Renal Pathology +15